Literature DB >> 23448611

Low molecular weight heparin prevents CLP-induced acute lung injury in rats by anti-inflammatory coagulation.

Xiao Lu1, Liang Zhao, Yong-Hua Xu.   

Abstract

The aim of our study was to observe the influence of low molecular Weight heparin (LMWH) on systemic inflammation, including high mobility group box 1 protein (HMGB1) and protective effect on acute lung injury induced by cecal ligation and puncture(CLP). Discuss the mechanism of this effect. 144 male SD rats were randomly divided into sham operation group (A), normal treatment group (B), the LMWH treatment group (C), n=48.Group A received a sham operation and the other groups were underwent CLP operation. Groups A and B accepted intraperitoneal injection (i.p.) of normal saline (NS) at a dose of 2.0 ml/kg and ceftriaxone (30 mg/kg), Group C were intraperitoneal injection additional LMWH (150 U/kg) except saline and ceftriaxone. Observe points were made at 3, 6, 12, 18, 24, 48 h, the rats were anesthetized and killed, mortality, lungs wet/dry ratio and Pathology change were determined. HMGB-1 mRNA, protein of lung tissues was calculated by RT-PCR and Western blot. TNF-α and IL-6 of blood plasma calculated by ELSIA. There was significantly different in each index between A and B group (p<0.05).Compared with CLP group, there was a significant decrease in the lung injury, the mortality, HMGB1 mRNA and protein expression on lung tissues (p<0.05). LMWH can decreases cytokine, HMGB1 levels of lung tissue during CLP-induced inflammation. As a result, LMWH ameliorated lung pathology and reduces mortality in CLP-induced systemic inflammation in a rat model. This effect may be mediated through the inhibition of axis of inflammation and coagulation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23448611      PMCID: PMC4333919          DOI: 10.17305/bjbms.2013.2419

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  17 in total

Review 1.  Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins.

Authors:  M Bustin
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

Review 2.  Effects of anticoagulant strategies on activation of inflammation and coagulation.

Authors:  Clemens Feistritzer; Christian J Wiedermann
Journal:  Expert Opin Biol Ther       Date:  2007-06       Impact factor: 4.388

3.  HMG-1 as a late mediator of endotoxin lethality in mice.

Authors:  H Wang; O Bloom; M Zhang; J M Vishnubhakat; M Ombrellino; J Che; A Frazier; H Yang; S Ivanova; L Borovikova; K R Manogue; E Faist; E Abraham; J Andersson; U Andersson; P E Molina; N N Abumrad; A Sama; K J Tracey
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

4.  High mobility group box-1 expression correlates with poor outcome in lung injury patients.

Authors:  Alessandra Bitto; Mario Barone; Antonio David; Francesca Polito; Dario Familiari; Francesco Monaco; Massimiliano Giardina; Teresa David; Roberto Messina; Alberto Noto; Vincenzo Di Stefano; Domenica Altavilla; Antonio Bonaiuto; Letteria Minutoli; Salvatore Guarini; Alessandra Ottani; Francesco Squadrito; Francesco Saverio Venuti
Journal:  Pharmacol Res       Date:  2009-08-08       Impact factor: 7.658

5.  High-mobility group box 1 protein promotes development of microvascular thrombosis in rats.

Authors:  T Ito; K Kawahara; T Nakamura; S Yamada; T Nakamura; K Abeyama; T Hashiguchi; I Maruyama
Journal:  J Thromb Haemost       Date:  2007-01       Impact factor: 5.824

6.  [Relation between level of expression of high mobility group protein B1 in hepatic tissue with the severity and prognosis of sepsis in rat].

Authors:  Yi-ming Shao; Hua-guo Yao; Xiao-zhong Liang; Yan-huo Xia
Journal:  Zhongguo Wei Zhong Bing Ji Jiu Yi Xue       Date:  2006-11

7.  RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages.

Authors:  R Kokkola; A Andersson; G Mullins; T Ostberg; C-J Treutiger; B Arnold; P Nawroth; U Andersson; R A Harris; H E Harris
Journal:  Scand J Immunol       Date:  2005-01       Impact factor: 3.487

Review 8.  Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention?

Authors:  R C Chambers
Journal:  Br J Pharmacol       Date:  2008-01-28       Impact factor: 8.739

Review 9.  Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia--a review.

Authors:  Marcus J Schultz; Jack J Haitsma; Haibo Zhang; Arthur S Slutsky
Journal:  Crit Care Med       Date:  2006-03       Impact factor: 7.598

Review 10.  Therapeutic potential of HMGB1-targeting agents in sepsis.

Authors:  Haichao Wang; Shu Zhu; Rongrong Zhou; Wei Li; Andrew E Sama
Journal:  Expert Rev Mol Med       Date:  2008-11-04       Impact factor: 5.600

View more
  2 in total

1.  The inhibiting effect of intravenous anesthesia on adrenal gland functions under the sepsis condition.

Authors:  Te Wang; Changdong Liu; Pihong Wei; Lili Lv; Zaiqi Yang
Journal:  Int J Immunopathol Pharmacol       Date:  2017-04-13       Impact factor: 3.219

2.  Effects of atorvastatin combined with low-molecular-weight heparin on plasma inflammatory cytokine level and pulmonary pathophysiology of rats with sepsis.

Authors:  Fei Jing; Ming Li; Hongsheng Ren; Jitian Zhang; Qingchun Yao; Yufeng Chu; Chunting Wang
Journal:  Exp Ther Med       Date:  2016-05-20       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.